[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:vexas-syndrome":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":42,"states":47},"VEXAS Syndrome",5,4,[8,16,22,29,35],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT05027945","A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome",[12],"Phase 2","RECRUITING","2026-08-26T02:16:28.221034Z","2026-05-05T02:43:28.649636Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT06782373","A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)",[12],"2026-08-03T02:40:18.473189Z","2026-05-05T02:43:27.572182Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":27,"content_modified":28},"NCT06538181","Pacritinib in Vacuoles, E1 Ubiqutin-activating Enzyme, X-linked, Autoinflammatory, Somatic (VEXAS) Syndrome",[26],"Phase 1","2026-08-26T02:15:01.639696Z","2026-05-05T02:35:31.611351Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT06004349","Autoimmune and Autoinflammatory Genetics Study",[],"2026-08-26T02:17:03.534765Z","2026-05-13T02:55:06.400216Z",{"nct_id":36,"title":37,"phases":38,"status":39,"updated_at":40,"content_modified":41},"NCT07102849","Molecular and Clinical Analysis of Bone Marrow Failure: A Secondary Research Study",[],"ENROLLING_BY_INVITATION","2026-08-26T02:15:41.377360Z","2026-06-16T05:54:07.855055Z",[43],{"biomarker":44,"count":45,"slug":46},"Ubiquitin-Like Modifier-Activating Enzyme 1",3,"ubiquitin-like-modifier-activating-enzyme-1",[]]